| Issuer | % of Class | Filed |
|---|---|---|
|
Twin Vee PowerCats, Co.
13G
VEEE · 90177C200
|
7.1% |
3/25/2026
Event 3/23/2026
|
|
Celularity Inc.
13G/A
Amendment 1
CELU · 151190204
|
0% |
2/11/2026
Event 7/14/2025
|
|
Vision Marine Technologies Inc.
13G/A
Amendment 1
VMAR · 92840Q301
|
4.3% |
2/10/2026
Event 1/14/2026
|
|
Longeveron Inc.
13G/A
Amendment 1
LGVN · 54303L203
|
0% |
2/10/2026
Event 8/13/2025
|
|
Jaguar Health, Inc.
13G/A
Amendment 1
JAGX · 47010C805
|
0% |
2/10/2026
Event 1/12/2026
|
|
GRO Bio, Inc.
13G/A
Amendment 1
GRI · 3622AW403
|
0% |
2/10/2026
Event 12/30/2025
|
|
Calidi Biotherapeutics, Inc.
13G/A
Amendment 1
CLDI · 320703408
|
0% |
2/10/2026
Event 9/18/2025
|
|
GRI Bio, Inc.
13G
GRI · 3622AW403
|
11.8% |
12/29/2025
Event 12/12/2025
|
|
XORTX Therapeutics Inc.
13G
XRTX · 98420Q306
|
9.9% |
10/27/2025
Event 10/23/2025
|
|
BioCardia, Inc.
13G
BCDA · 09060U606
|
7.5% |
9/19/2025
Event 9/19/2025
|
|
Bionano Genomics, Inc.
13G
BNGO · 09075F404
|
5.4% |
9/17/2025
Event 9/17/2025
|
|
Silexion Therapeutics Corp.
13G
SLXN · G1281K122
|
6.2% |
9/15/2025
Event 9/12/2025
|
|
Purple Biotech Ltd.
13G
PPBT · 74638P208
|
9.9% |
9/9/2025
Event 9/4/2025
|
|
STRATA Skin Sciences, Inc.
13G
SSKN · 86272A305
|
6.9% |
9/4/2025
Event 9/3/2025
|
|
CEL-SCI Corporation
13G
CVM · 150837706
|
6.9% |
8/29/2025
Event 8/27/2025
|
|
Jaguar Health, Inc.
13G
JAGX · 47010C805
|
18.9% |
8/29/2025
Event 8/28/2025
|
|
Celularity Inc
13G
CELU · 151190204
|
5.1% |
8/27/2025
Event 7/14/2025
|
|
Vision Marine Technologies Inc.
13G
VMAR · 92840Q301
|
16.1% |
8/27/2025
Event 8/15/2025
|
|
Calidi Biotherapeutics, Inc.
13G
CLDI · 320703408
|
14.5% |
8/27/2025
Event 8/20/2025
|
|
Longeveron Inc.
13G
LGVN · 54303L203
|
6.1% |
8/27/2025
Event 8/8/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.